Cynosure Management, LLC 10x Genomics, Inc. Transaction History
Cynosure Management, LLC
- $680 Million
- Q3 2024
A detailed history of Cynosure Management, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 25,745 shares of TXG stock, worth $361,459. This represents 0.09% of its overall portfolio holdings.
Number of Shares
25,745Holding current value
$361,459% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$154 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$151 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$90.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$89.8 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$89.5 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.33B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...